SC 13G/A: Sagimet Biosciences Inc.

AI Summary

SC 13G/A filing by Sagimet Biosciences Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — uer) Series A Common Stock, par value $0.0001 per share (Title of Class of Securitie

Filing Documents

• p24-3185sc13ga.htm (SC 13G/A) — 40KB
• 0000902664-24-006615.txt ( ) — 42KB

(a)

Item 1(a). NAME OF ISSUER The name of the issuer is Sagimet Biosciences Inc. (the " Company ").

(b)

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES The Company's principal executive office is located at 155 Bovet Road, Suite 303, San Mateo, California 94402.

(a)

Item 2(a). NAME OF PERSON FILING This statement is filed by Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (" HIM " or the " Reporting Person "), with respect to the shares of Series A Common Stock (as defined in Item 2(d) below) held by SGMT Holdings Limited (" SGMT "). SGMT is wholly owned by Hillhouse Venture Fund V, L.P. (" Venture Fund V "). HIM acts as the sole management company of Venture Fund V. HIM is hereby deemed to be the sole beneficial owner of, and to solely control the voting and investment power of, the shares of Series A Common Stock held by SGMT.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE The address of the business office of the Reporting Person is Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands, KY1-9006.

(c)

Item 2(c). CITIZENSHIP Cayman Islands

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES Series A Common Stock, par value $0.0001 per share (the " Series A Common Stock ").

(e)

Item 2(e). CUSIP NUMBER 786700104 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; CUSIP No. 786700104 13G/A Page 4 of 5 Pages (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________________ Item 4. The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 30,674,855 shares of Series A Common Stock outstanding as of August 14, 2024, as reported in the Company's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on August 15, 2024. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for the Reporting Person and is incorporated herein by reference. Item 5. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: November 14, 2024 HILLHOUSE Investment MANAGEMENT, LTD. /s/ Audrey Woon Name: Audrey Woon Title: Chief Compliance Officer

View Full Filing

View this SC 13G/A filing on SEC EDGAR